Pegloticase immunogenicity: the relationship between efficacy and antibody development in patients treated for refractory chronic gout.
Pegloticase immunogenicity: the relationship between efficacy and antibody development in patients treated for refractory chronic gout. Arthritis Res Ther. 2014 Mar 04; 16(2):R60.